Sponsors
Silver Sponsors
Napo Pharmaceuticals, a Jaguar Health family company, focuses on developing and commercializing proprietary, plant-based human gastrointestinal pharmaceuticals from plants harvested responsibly from rainforest areas. Along with our European affiliate, Napo Therapeutics S.p.A., we are focused on the development program of our novel powder for oral solution formulation of crofelemer for treatment of rare intestinal failure indications, including pediatric microvillus inclusion disease (MVID) and adult short bowel syndrome with intestinal failure (SBS-IF).
Sanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.
Fresenius Kabi, A Company Built on a Promise For us, care is a fundamental obligation, mission, and daily source of inspiration. It is the momentum that pushes us forward to help elevate the quality of life for both caregivers and those who need it most: critically and chronically ill patients. By providing essential medicines and technologies for infusion, transfusion, and medical nutrition, we are helping advance the future of healthcare, making it even more accessible, reliable, and in tune with current and future needs.
At Sandoz, our Purpose is pioneering access for patients. It shines through in our rich heritage, as well as in our plans for the future of our business. We are delivering on our purpose by extending our global leadership in off-patent medicines. It’s what we do best: making quality medicine accessible to more patients whenever and wherever they need it.
Sandoz broad global portfolio comprises about 1,300 quality generic and biosimilar medicines. In 2025 we reached more than one billion patients, generating USD 26 billion in healthcare system savings in the US, Europe, and other key markets, resulting in a total social impact of around USD 400 billion worldwide.
Sandoz impact worldwide is considerable, we provide more than 800 million patient treatments per year, driving substantial savings for healthcare systems and generating a positive social impact, estimated in the hundreds of billions of dollars. We intend to make an even bigger difference in the future, for a world that needs affordable, and sustainable high-quality healthcare more than ever before.
With patients in mind: Success in biosimilars and generics is not only about developing and manufacturing affordable, high-quality medicines. With patients in mind, we help patients to access the medicines they need at the right time, we collaborate with patient organizations to improve access to biologic medicines, and we support the patient community by amplifying their voice and co-creating programs that address their needs.
At Ipsen, we’re dedicated to improving people’s lives and health outcomes. Our 5,000 employees around the world are committed to tackling areas of high unmet medical need to improve the quality of life of patients and caregivers.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in healthcare
in approximately 80 countries.
Pharmalink is a leading UAE-based healthcare organization with over 30 years of experience, dedicated to enhancing patient access to high-quality medical solutions across the GCC region. Their comprehensive portfolio includes pharmaceuticals, biosimilars, and branded generics, addressing diverse therapeutic areas such as rare disease , Neurology , gastroenterology, oncology, and cardiovascular health. By partnering with global healthcare innovators, Pharmalink continues to fulfill its mission of improving community health outcomes.
Exhibitors
Established in Dubai, United Arab Emirates, in 2021 formed by members who have over a decade of experience and expertise in direct marketing, product knowledge, sales and achieving targets.
Endo Hub Medical Supplies Strives to be recognized as a leading Healthcare Provider within the UAE through its distinguished business approach, By building strong relationships with customers and health stakeholders By offering best services and values in Healthcare, and to deliver a comprehensive range of medical consumables.
Alphamed was set up in 1982 by Dr. Saad F. Al Khayyat the company that was the foundation of Al Khayyat Investments. Al Khayyat Investments is on the threshold of a dynamic new phase of expansion, both domestically and regionally. Our financial position is strong. We have a committed, mature management team who have built on their rich, cumulative experience, gained across numerous geographies, to lead AKI into a position of strength in the UAE and beyond. Our infrastructure is powerful and well developed. Our vision is to retain our leading position in the market and grow further. Al Khayyat Investments trades across eight operating divisions, led by distinguished professionals drawn from a broad spectrum of industries.
AVANOS Medical is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter.
AVANOS Medical's products are designed to improve patient outcomes and enhance the efficiency of healthcare delivery.
Boston Scientific Corporation (NYSE: BSX) is a leading global medical technology company that develops, manufactures, and markets less-invasive medical devices.
Company Overview
-
Headquarters: Marlborough, Massachusetts, USA
-
Founded / Incorporated: 1979
-
Commercial Reach: Products distributed to roughly 127–130 countries
-
Patient Impact: Treats over 48 million patients annually
Al Khayyat Investments (AKI) is a diversified Emirati family holding company founded in 1965 by Dr. Saad F. Al Khayyat, headquartered in Dubai, UAE.
Company Overview
-
Founder & Chairman: Dr. Saad F. Al Khayyat
-
Managing Director: Zaid S. Al Khayyat
-
Employees: 12,000+
-
Geographic Footprint: UAE, Saudi Arabia, Qatar, Bahrain, Kuwait, Oman, Egypt, Jordan, and Iraq
-
Core Origin: Started with the establishment of BinSina Pharmacy
axter is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: Bioscience and Medical Products. Baxter's Bioscience business produces recombinant and blood plasma proteins to treat haemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute bloodrelated conditions; products for regenerative medicine, and vaccines. Baxter's Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat endstage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and haemodialysis.
Novalac specializes in infant and young child nutrition, offering a comprehensive range of formulas to support growth and address specific nutritional needs. With a strong focus on research and pediatric gastroenterology, Novalac provides targeted nutritional solutions for feeding concerns such as regurgitation, colic, constipation, and cow milk protein allergy. Its products are developed in collaboration with healthcare professionals, with a commitment to scientific evidence and quality.
Dupharm was established in 1994 as one of the leading distributor in UAE. We had created the best infrastructure and manpower resources to assure long-lasting relationship with our partners and customers.
Dupharm offers a large portfolio of top of the range healthcare products. We take pride in offering best in class sales and service by finding innovative and customized solutions to cater to customer requirements.